Projects per year
Personal profile
Area of Expertise
The O’Bryant laboratory is dedicated to precision medicine in Alzheimer’s disease and other neurodegenerative diseases, including Down syndrome, Lewy Body disease, Parkinson’s disease, traumatic brain injury, and others. The fully translational lab has a Biomarker Core (Dr. Hall, Director), Clinical Core (Dr. Johnson, Director), Administrative Core (Dr. O’Bryant, Director) and Data Core (Dr. Johnson, Director). The lab also has a Neuroimaging Core (USC, Dr. Toga, Director). Dr. O’Bryant's multiple NIH grants focus on novel strategies for disease detection, screening into trials (therapeutic and prevention), and patient stratification for optimal treatment response. As part of this work, the lab has a strong focus on the impact of ethnicity/diversity on cognitive loss during the aging process and runs the one-of-a-kind Health & Aging Brain among Latino Elders (HABLE) study, which is the most comprehensive study of Mexican-American brain aging to date.
Education/Academic qualification
PhD in Clinical Psychology, University at Albany
MA in Clinical Psychology, University at Albany
BS in Psychology, Louisiana State University
Fingerprint Dive into the research topics where Sid O'Bryant is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 12 Similar Profiles
Alzheimer Disease
Medicine & Life Sciences
Biomarkers
Medicine & Life Sciences
Dementia
Medicine & Life Sciences
Malingering
Medicine & Life Sciences
Cognition
Medicine & Life Sciences
Depression
Medicine & Life Sciences
Neuropsychology
Medicine & Life Sciences
Hispanic Americans
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 2012 2024
Blood-Based Biomarker Profiles for a Precision Medicine Approach to Parkinsons Disease
O'Bryant, S., Hall, J. & Nandy, R.
15/10/19 → 14/10/20
Project: Research
Blood Biomarkers for Discriminating Amongst Neurodegenerative Diseases
O'Bryant, S., Hall, J. & Nandy, R.
Michael J. Fox Fnd for Parkinson's Res
1/06/19 → 31/05/20
Project: Research
Detection of Elder Abuse Through Emergency Care Technicians (DETECT)
University of Texas HSC at Houston
15/09/18 → 31/05/23
Project: Research
Research Output 2003 2019
1
Citation
(Scopus)
A proteomic signature for dementia with Lewy bodies
O'Bryant, S. E., Ferman, T. J., Zhang, F., Hall, J., Pedraza, O., Wszolek, Z. K., Como, T., Julovich, D., Mattevada, S., Johnson, L. A., Edwards, M. & Graff-Radford, N. R., Dec 2019, In : Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring. 11, p. 270-276 7 p.Research output: Contribution to journal › Article
Open Access
Lewy Body Disease
Proteomics
Parkinson Disease
Dementia
Sensitivity and Specificity
Assessing Neuronal and Astrocyte Derived Exosomes From Individuals With Mild Traumatic Brain Injury for Markers of Neurodegeneration and Cytotoxic Activity
Winston, C. N., Romero, H. K., Ellisman, M., Nauss, S., Julovich, D. A., Conger, T., Hall, J. R., Campana, W., O’Bryant, S. E., Nievergelt, C. M., Baker, D. G., Risbrough, V. B. & Rissman, R. A., 2 Oct 2019, In : Frontiers in Neuroscience. 13, 1005.Research output: Contribution to journal › Article
Open Access
Brain Concussion
Exosomes
Astrocytes
Proteins
Neurogranin
Author Correction: Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (Nature Genetics, (2019), 51, 3, (414-430), 10.1038/s41588-019-0358-2)
Alzheimer Disease Genetics Consortium (ADGC), The European Alzheimer’s Disease Initiative (EADI), Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium (CHARGE) & Genetic and Environmental Risk in AD/Defining Genetic, Polygenic and Environmental Risk for Alzheimer’s Disease Consortium (GERAD/PERADES), 1 Sep 2019, In : Nature Genetics. 51, 9, p. 1423-1424 2 p.Research output: Contribution to journal › Comment/debate
Open Access
Meta-Analysis
Immunity
Alzheimer Disease
Lipids
1
Citation
(Scopus)
Blood-based biomarkers for Down syndrome and Alzheimer's disease: A systematic review
Petersen, M. E. & O'Bryant, S., 1 Jul 2019, In : Developmental Neurobiology. 79, 7, p. 699-710 12 p.Research output: Contribution to journal › Review article
Down Syndrome
Alzheimer Disease
Biomarkers
Chromosomes, Human, Pair 21
Prodromal Symptoms
2
Citations
(Scopus)
Blood Biomarkers for Use in Alzheimer Disease - Moving from "if" to "how?"
O'Bryant, S., 1 Sep 2019, In : JAMA Neurology. 76, 9, p. 1009-1010 2 p.Research output: Contribution to journal › Editorial
Alzheimer Disease
Biomarkers